Hyperlysinemia is a rare inherited condition in which the body has trouble breaking down the amino acid lysine. Many people with Hyperlysinemia are identified in infancy or childhood, but some have no clear problems and are found only through testing. Early signs of Hyperlysinemia can include developmental delay, low muscle tone, or seizures, though not everyone will have the same experience. Hyperlysinemia is usually lifelong, and treatment often focuses on managing seizures or developmental needs, with diet changes used in some cases. In many people, Hyperlysinemia does not clearly shorten life expectancy, but outlook can vary depending on the severity of a person’s features and any related neurologic problems.
How many people live with Hyperlysinemia?
Hyperlysinemia is so rare that there is no direct worldwide or U.S. count; rare-disease databases list it as affecting fewer than 1 in 1 million people (Orphanet, 2024). Using that as a rough upper limit, fewer than about 8,200 people worldwide (Orphanet, 2024; United Nations, 2024) and fewer than about 340 people in the United States (Orphanet, 2024; U.S. Census Bureau, 2024) may be living with it, although the true number is uncertain and likely much lower.
Overview
HyperlysinemiaSymptoms
Hyperlysinemia often has no obvious signs, and many people feel well. When features do occur, they can include developmental delay, low muscle tone, seizures, or learning problems, but severity varies widely and some people have only mild findings.
Outlook and prognosis
For many people, hyperlysinemia causes few or no day-to-day problems, and life expectancy is usually normal. When symptoms such as developmental delay or seizures are present, outlook depends more on those challenges and the support each person needs.
Causes and risk factors
Hyperlysinemia is caused by changes in the AASS gene. It usually happens when a child inherits one changed copy from each parent. Risk is higher if both parents are carriers or are close blood relatives.
Genetic influences
Genetics are central to Hyperlysinemia. It is usually caused by inherited changes in genes involved in breaking down lysine, and these genetic variations can influence how strongly Hyperlysinemia shows up from one person to another.
Diagnosis
Hyperlysinemia is often suspected from clinical features or newborn screening. Blood and urine tests can show high lysine levels. Genetic diagnosis of Hyperlysinemia confirms the cause, and some people also need imaging or other lab tests.
Treatment and drugs
Hyperlysinemia often needs monitoring rather than active treatment, especially when it causes no symptoms. If symptoms occur, care focuses on problems such as seizures, feeding difficulties, or delayed development. A metabolic specialist may guide nutrition and supportive therapies.
Symptoms
Many people with Hyperlysinemia have no noticeable health problems and only learn about it after blood tests or genetic testing. When signs do occur, the early features of Hyperlysinemia can include delays in development, seizures, or muscle tone and movement problems. Features vary from person to person and can change over time. Some people remain well, while others may need support with learning, mobility, or seizure care.
Many people with Hyperlysinemia do not have clear day-to-day problems. In these cases, eating, growing, and usual activities may seem completely typical.
Some children reach milestones like sitting, walking, or talking later than expected. They may also need extra help with learning, language, attention, or problem-solving as they grow.
Some people with Hyperlysinemia have seizures, which may look like staring spells, body stiffening, jerking, or sudden loss of awareness. Seizures can range from brief episodes to more noticeable events that need ongoing treatment.
Low muscle tone or unusual stiffness can affect posture, movement, and endurance. For many people with Hyperlysinemia, this can mean tiring more easily, walking differently, or needing physical therapy support.
How people usually first notice Hyperlysinemia?
Hyperlysinemia is often first noticed not because a baby looks ill, but because newborn screening or later blood and urine tests show unusually high levels of lysine, an amino acid the body normally breaks down. In some children, the first signs of hyperlysinemia can include low muscle tone, feeding difficulties, developmental delay, or seizures, although many people with this condition have few or no obvious symptoms. Because it can vary so much from one child to another, doctors usually confirm how hyperlysinemia is first noticed with follow-up metabolic testing and a careful look at growth and development.
Types of Hyperlysinemia
Hyperlysinemia can look quite different from one family to another, and many people have few or no day-to-day problems. In practice, the types of Hyperlysinemia are usually described by the part of lysine breakdown that is affected, which can change how severe the condition is and which lab findings show up. Symptoms don’t always look the same for everyone.
Classic hyperlysinemia
This is the better-known form, usually linked to reduced activity of the enzyme that helps break down lysine. Many living with this form have mild symptoms or none at all, while others may have developmental delay, low muscle tone, or seizures.
Saccharopinuria form
This rarer variant involves buildup of both lysine and saccharopine, another substance made during lysine breakdown. It may be more likely to cause neurologic problems, and early symptoms of Hyperlysinemia in this form can include feeding difficulties, developmental concerns, or seizures.
Can I slow down the onset of symptoms?
Probably not: for hyperlysinemia, there is no good evidence that lifestyle changes or medicine can reliably delay the start of symptoms. Because this condition is mainly caused by an inherited problem in how the body handles part of protein, everyday habits like diet, exercise, sleep, or supplements have not been shown to meaningfully postpone symptoms, and many people with hyperlysinemia never develop clear problems at all. If hyperlysinemia is found early, regular follow-up with a specialist can help watch for seizures, learning issues, or other concerns, and while diet changes are sometimes tried in some cases, they are not a proven way to prevent symptoms; staying connected with care is still the best step.
What genetics can tell you about symptoms
In hyperlysinemia, genetics can confirm the diagnosis, but they usually do not predict exactly which symptoms someone will have in day-to-day life. Many people with the same genetic change have very different experiences, ranging from no clear symptoms to developmental delay, seizures, or low muscle tone, so the gene change does not neatly forecast severity or age at onset. In general, genetics tells you the condition is present, while symptoms and their timing can vary widely from one person to another.
Causes and risk factors
Hyperlysinemia is usually caused by inherited changes in the AASS gene, which helps the body break down the amino acid lysine. A child usually develops Hyperlysinemia only if both parents pass down a changed copy of this gene. Family history and parents who are blood relatives can raise the chance of this rare condition. There are no known lifestyle choices or common environmental exposures that cause Hyperlysinemia. Knowing your family history is a good first step when looking at risk factors for Hyperlysinemia.
What are the most common causes or risk factors?
The main cause of hyperlysinemia is a rare inherited change in a gene that helps the body break down lysine, which is one of the natural building blocks of protein. The biggest risk factors are having a family history of the condition, having two parents who both carry the gene change, and being born to parents who are related by blood, such as cousins, which makes it more likely that a child will inherit the same changed gene from both sides. There are no well-known lifestyle or environmental risk factors, so it is not usually caused by diet, exercise, or anything a parent did during pregnancy.
Environmental and biological risk factors
Hyperlysinemia is a very rare condition that is usually present from birth. When people look for risk factors for hyperlysinemia, it helps to know that doctors have not identified clear environmental causes or common non-inherited biological factors that increase the chance of it occurring. Awareness of both biological and environmental influences helps you feel prepared.
Current evidence has not shown clear links between hyperlysinemia and factors such as maternal age, routine pregnancy illnesses, birth complications, or common environmental exposures. In other words, there are no well-established environmental or non-genetic biological risk factors that are known to drive this condition.
Genetic risk factors
Hyperlysinemia is often found on lab testing rather than from obvious day-to-day symptoms, which can make the news surprising for families. The main genetic causes of hyperlysinemia are inherited changes in a gene that helps the body break down lysine, an amino acid from protein. It usually happens only when a child receives a changed copy of that gene from both parents. Some risk factors are inherited through our genes.
AASS gene: Hyperlysinemia is most often caused by changes in the AASS gene, which helps the body break down lysine. When both copies of this gene do not work as expected, lysine can build up in the blood and urine.
Recessive pattern: Hyperlysinemia usually follows an inherited pattern called autosomal recessive, which means a child needs two changed copies of the gene to have the condition. People with one changed copy are carriers and usually do not have health problems from being a carrier.
Carrier parents: When both parents are carriers, each pregnancy has a 1 in 4, or 25%, chance that the child will have hyperlysinemia. Each pregnancy also has a 1 in 2, or 50%, chance that the child will be a carrier.
Family history: Having a brother, sister, or other close relative with hyperlysinemia raises the chance that the same gene change is present in the family. This can help explain why the condition sometimes appears in more than one child in a family.
Related parents: The chance is higher when parents are biologically related, because relatives are more likely to carry the same rare gene change from a shared ancestor. This does not create the gene change, but it makes it more likely that a child could inherit two changed copies.
Lifestyle risk factors
Hyperlysinemia is inherited, so lifestyle habits do not cause it. However, how lifestyle affects Hyperlysinemia can matter for symptom control, metabolic stability, and the chance of complications in people who are sensitive to high lysine levels. The most relevant factors are diet, illness routines, and how closely any prescribed metabolic plan is followed.
A high-protein diet can raise lysine intake and may worsen metabolic imbalance in people with symptomatic Hyperlysinemia. If a clinician has advised protein or lysine moderation, following that plan can help limit biochemical stress and related symptoms.
Frequent intake of lysine-rich foods such as large amounts of meat, cheese, eggs, and some protein supplements may increase lysine levels further. This can be especially important in individuals whose symptoms seem to flare with higher lysine exposure.
In people prescribed a specialized diet, inconsistent adherence can make lysine control less stable over time. Careful meal planning and regular follow-up with a metabolic dietitian may reduce symptom variability and support growth and development.
Long gaps without eating can place extra metabolic stress on the body, especially during childhood or in people with more active disease. Regular meals and sick-day nutrition plans may help prevent decompensation when appetite is poor.
Risk prevention
With hyperlysinemia, there is usually no proven way to prevent the condition itself because it is inherited. For many living with hyperlysinemia, prevention is mainly about finding it early, watching for possible complications, and supporting growth and development if symptoms appear. Different people need different prevention strategies—there’s no single formula. This matters because early symptoms of hyperlysinemia, when they occur, can overlap with other childhood concerns such as delays in development or seizures.
If hyperlysinemia runs in your family, genetic counseling can help you understand the chance of having an affected child. It can also explain testing options before or during pregnancy in a clear, practical way.
When there is a family history, early newborn or family testing may help identify hyperlysinemia before problems appear. Earlier diagnosis can make it easier to track development and respond quickly if symptoms start.
Ongoing visits with a pediatrician or metabolic specialist can help monitor growth, learning, and neurologic health in children with hyperlysinemia. This is especially useful because some people stay well, while others may need closer support.
Routine checks for speech, learning, movement, and behavior can catch concerns early. If delays are found, therapies such as physical, occupational, or speech support may improve day-to-day function.
Can you prevent Hyperlysinemia?
Hyperlysinemia usually cannot be prevented because it is an inherited condition that a child is born with. If it runs in your family, genetic testing and talking with a genetics specialist before pregnancy may help you understand the chances of passing it on, but this does not guarantee prevention. Early testing after birth can help families get support and care sooner, even though it does not stop the condition from happening.
Transmission
Hyperlysinemia is not infectious, so it cannot spread from one person to another through coughing, kissing, sharing food, sex, or everyday contact. Instead, the genetic transmission of Hyperlysinemia usually happens when a child inherits one changed gene from each parent.
This means parents are often healthy carriers and may not know they can pass it on. For each pregnancy between two carriers, there is a 1 in 4 chance the child will have Hyperlysinemia, a 1 in 2 chance the child will be a carrier, and a 1 in 4 chance the child will inherit neither changed copy.
When to test your genes
Consider genetic testing if newborn screening or blood amino acid testing shows persistently high lysine, or if there is a family history of hyperlysinemia. It can confirm the diagnosis, help rule out related metabolic conditions, and guide genetic counseling for future pregnancies.
Diagnosis
Hyperlysinemia is often found after a blood test shows unusually high levels of the amino acid lysine, sometimes before it causes clear day-to-day problems. Some people with Hyperlysinemia have developmental delays, low muscle tone, or seizures, while others have few or no symptoms, so diagnosis usually depends on test results rather than symptoms alone. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of Hyperlysinemia is usually confirmed by combining lab findings with genetic testing.
Doctors measure amino acids in a blood sample to see whether lysine is much higher than expected. This is often the first major clue and can prompt the genetic diagnosis of Hyperlysinemia.
Urine tests may look for extra lysine and related breakdown products that suggest the body is not processing this amino acid normally. These results can support the blood test findings and help rule out other metabolic conditions.
Genetic tests can check for changes in the gene linked to the most common form of Hyperlysinemia. Finding a disease-causing variant helps confirm the diagnosis and may clarify whether other family members could also carry the change.
Doctors review growth, development, muscle tone, and any history of seizures or learning difficulties. A detailed family and health history can help because some conditions have a genetic link, meaning they can run in families.
How is Hyperlysinemia diagnosed?
Hyperlysinemia is usually diagnosed with blood tests that show unusually high levels of lysine, a building block of protein, and doctors may also use urine tests to look for related changes. The diagnosis is based on these lab results along with the person’s symptoms, growth and development, and family history, because some people have very mild signs or none at all. Genetic testing can help confirm the diagnosis by looking for a change in the gene linked to this condition, but it is usually used to support the diagnosis rather than replace the blood tests.
Stages of Hyperlysinemia
Hyperlysinemia does not have defined progression stages. This is because it is usually identified by a lasting difference in how the body breaks down the amino acid lysine, rather than a condition that moves through clear step-by-step phases over time. Many living with hyperlysinemia have no symptoms, while others may be evaluated because of developmental concerns or findings on blood tests, so the signs can vary from one person to another. Different tests may be suggested to help confirm the diagnosis, including blood or urine testing, and in some cases genetic testing if doctors are trying to understand possible early symptoms of hyperlysinemia or clarify what a lab result means.
Outlook and prognosis
The outlook for people with hyperlysinemia is generally favorable, especially in individuals who remain asymptomatic or have only mild developmental or neurologic findings. Many affected people are identified incidentally and can have a normal lifespan, although some reported cases have included developmental delay, seizures, hypotonia, or learning difficulties, making prognosis variable from person to person. Because hyperlysinemia is rare and the severity is inconsistent, long-term outcome depends largely on whether neurologic symptoms are present and whether there are other contributing conditions. Available evidence does not suggest that isolated hyperlysinemia usually causes progressive organ failure or markedly shortened life expectancy. Mortality specifically attributable to hyperlysinemia appears to be uncommon, but severe neurologic complications in some individuals may worsen overall health and functional outcome. Regular follow-up with metabolic and neurologic specialists can help monitor development, manage symptoms, and support the best possible quality of life.
Long-term effects
For many people, the long-term effects of hyperlysinemia are mild or not noticeable in daily life. Long-term effects vary widely, and some people are found to have hyperlysinemia only after testing done for another reason. In others, especially when developmental concerns are present in childhood, the outlook may include lasting effects on learning or the nervous system. Because this condition is very rare, some reported long-term features are not fully predictable and may differ from one family to another.
Many people with hyperlysinemia have normal growth and development over time. In these cases, the condition may remain a lab finding without causing obvious long-term health problems.
Some children with hyperlysinemia have developmental delay, and this can continue into school age as learning or speech differences. The degree can range from mild support needs to more significant intellectual disability.
Some people living with hyperlysinemia have seizures, especially when neurologic features are part of their condition. When seizures occur, they may become a long-term part of the health picture rather than a one-time event.
Low muscle tone can affect posture, coordination, and motor milestones in some children with hyperlysinemia. Over time, this may mean ongoing clumsiness, delayed physical skills, or slower progress with activities that need balance and strength.
How is it to live with Hyperlysinemia?
For many people living with hyperlysinemia, daily life is often little changed because this rare inherited condition commonly causes no symptoms and may only be found on metabolic testing. Some people, however, may also have developmental delays, low muscle tone, or seizures, so day-to-day life can vary and may include therapy visits, school support, or regular follow-up with a metabolic specialist. For families, the condition can bring uncertainty at first, but in many cases the practical impact is modest, and learning what signs to watch for can make life feel more predictable and manageable.
Treatment and drugs
Hyperlysinemia is often mild, and many people living with hyperlysinemia do not need specific treatment for the high lysine level itself. Care usually focuses on regular follow-up with a metabolic specialist, watching growth, development, and any related problems such as learning issues or seizures if they occur. Treatment often looks different for each person, and in the small number of people who have symptoms, care may include seizure medicines, developmental therapies, and sometimes a carefully planned diet under specialist guidance. Because hyperlysinemia is rare and the early symptoms of hyperlysinemia can vary, families usually benefit from individualized advice rather than a one-size-fits-all plan.
Can you cure Hyperlysinemia?
No, there is no cure for hyperlysinemia right now. Many people with hyperlysinemia never develop health problems and may not need treatment at all. If symptoms do happen, care usually focuses on regular follow-up and treating specific problems, and some people may be advised to make diet changes, but this manages the condition rather than curing it.
Non-drug treatment
Many people with hyperlysinemia have no day-to-day symptoms and do not need active treatment. When support is needed, care usually focuses on development, learning, and nutrition rather than medicine. For many, treatment begins not at the pharmacy, but with regular follow-up to see how a child is growing, learning, and doing at school. Because this condition can vary, the best plan depends on whether hyperlysinemia is causing problems or was simply found on testing.
Checkups help track growth, development, and any changes over time. This is especially useful when hyperlysinemia is found on newborn screening or blood tests and it is not yet clear whether it will affect daily life.
Early support such as speech, physical, or occupational therapy can help if a child has delays with movement, communication, or learning. Some non-drug options are delivered by specialists and are tailored to the skills that need the most support.
A metabolic dietitian may review eating patterns and overall nutrition, especially in children. A low-lysine diet has been tried in some cases, but it is not routinely needed for everyone with hyperlysinemia and should only be done with specialist supervision.
School-based services can help with attention, language, or learning challenges if these are present. For many families, this can mean simple steps like extra time, speech support, or a more structured classroom plan.
Your genes may have an impact on how drugs work for you
For people with hyperlysinemia, genes are already part of the condition itself, but there is no well-established evidence that this condition usually changes how common medicines work in a predictable, condition-specific way. In day-to-day care, treatment is often more about watching for symptoms and managing related problems than using a standard medicine for hyperlysinemia itself. Even so, many living with hyperlysinemia may be more carefully monitored when starting new medicines, especially during illness or times of stress, because the body’s chemistry can sometimes be more sensitive than usual.
Pharmacological treatments
For many living with hyperlysinemia, there is no routine medicine taken to treat the underlying condition itself. Hyperlysinemia is usually managed with monitoring and, when needed, treatment of symptoms rather than a drug that directly lowers lysine levels. This means the best treatment for hyperlysinemia often depends on whether someone has related problems such as seizures or developmental concerns.
There is no widely accepted medication that directly treats the cause of hyperlysinemia or reliably lowers lysine levels in everyday care. In many people, especially those without clear symptoms, no drug treatment is needed.
If hyperlysinemia is linked with seizures, doctors may use standard anti-seizure medicines such as levetiracetam, valproate, or other seizure drugs based on age, seizure type, and overall health. Not everyone responds to the same medication in the same way.
Some people with hyperlysinemia may also receive medicines for related symptoms, such as sleep, behavior, or attention problems, if those issues are present. These drugs do not treat the metabolic condition itself, but they can help with day-to-day functioning.
Because hyperlysinemia can vary a lot from one person to another, medication plans are usually tailored rather than routine. Doctors may review symptoms over time and only prescribe medicine if a clear problem needs treatment.
Genetic influences
For many families, hyperlysinemia first becomes a genetics question after a routine blood test shows high lysine levels in a baby or child. Hyperlysinemia is usually caused by changes in the AASS gene, which helps the body break down the amino acid lysine. It is inherited in an autosomal recessive pattern, which means a child has to receive one nonworking copy of the gene from each parent. A carrier means you hold the gene change but may not show symptoms. This is why parents are often healthy themselves and only learn about the condition after their child is tested. Even within the same family, people with hyperlysinemia can be affected differently, so understanding how hyperlysinemia is inherited can help with family planning, testing for relatives, and genetic counseling.
Is Hyperlysinemia genetic?
Genetics are central to Hyperlysinemia. It is usually caused by inherited changes in genes involved in breaking down lysine, and these genetic variations can influence how strongly Hyperlysinemia shows up from one person to another.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most of these variants do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people living with Hyperlysinemia, the biggest question is whether the genetic finding will change treatment. In most cases, the gene change helps confirm that the body does not break down lysine, an amino acid from food, in the usual way, but it does not point to one specific medicine that reliably treats Hyperlysinemia. Not every difference in response is genetic, but in Hyperlysinemia the genetic result is still useful because it can help doctors confirm the diagnosis, rule out similar metabolic conditions, and decide whether simple monitoring, diet changes, or treatment for symptoms such as seizures or developmental concerns is needed. Many living with Hyperlysinemia do not need a standard drug treatment at all, and there is no widely used gene-targeted medication for this condition at present. So when people ask how genetics affect Hyperlysinemia treatment, the main role of testing is usually to guide diagnosis and overall care planning rather than to choose between different medicines.
Interactions with other conditions
Hyperlysinemia does not have many well-established links with other diseases, and for many people it is found during testing rather than because it clearly causes other health problems. In some families, people with hyperlysinemia have also had developmental delay, low muscle tone, or seizures, but experts do not always know whether the high lysine level is the main cause, a contributing factor, or simply found alongside another condition. Having more than one diagnosis can make symptoms feel harder to untangle, especially when early symptoms of hyperlysinemia overlap with more common neurologic or developmental conditions. This means doctors may look carefully for other causes if someone has learning difficulties, movement concerns, or epilepsy, instead of assuming hyperlysinemia explains everything. At this point, hyperlysinemia is not known to strongly raise the risk of common illnesses such as diabetes, heart disease, or autoimmune disease. Because it is rare and can look different from person to person, follow-up with a metabolic or genetics specialist can help make sure any other condition is recognized and treated on its own.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Hyperlysinemia?
Because hyperlysinemia can sometimes be linked with seizures, low muscle tone, or delayed development, doctors may also consider other inherited conditions that affect how the body breaks down protein or makes energy, as well as more common causes of these problems such as epilepsy or cerebral palsy. In some children, learning or behavior differences may also overlap with developmental conditions such as autism, so careful testing is often needed to tell them apart.
History
Hyperlysinemia has not always been easy to recognize, partly because many people living with it have few symptoms or none at all. That has shaped its history: for years, it was often found only when doctors were testing amino acids, the small building blocks the body uses from protein, rather than because someone looked obviously ill. In daily life, this can mean a child seems well overall, and the condition comes up unexpectedly during lab work done for another reason.
Early medical reports described unusually high levels of lysine, an amino acid, in blood and urine and linked this finding to a metabolic condition now known as hyperlysinemia. Once considered rare, now recognized as something that can vary widely from one person to another, hyperlysinemia has been studied for decades through case reports, family studies, and improved laboratory testing. Some early reports grouped together people with very different health issues, so it was not always clear which problems were truly caused by hyperlysinemia and which were unrelated.
As medical science evolved, researchers became better at separating hyperlysinemia from other metabolic disorders that can look similar on lab tests. This mattered because early symptoms of hyperlysinemia, when they happen at all, can be nonspecific, such as developmental concerns, low muscle tone, or seizures, while many others remain healthy and never develop clear problems from the condition. Over time, newer testing methods helped doctors identify milder cases that would likely have been missed in the past.
Researchers later identified a genetic cause for hyperlysinemia, which helped confirm that it is an inborn metabolic condition rather than just an unusual lab result with no explanation. Even so, the history of hyperlysinemia is a good reminder that not every abnormal test means the same thing for every family. Knowing this background can make today’s medical advice feel more understandable: careful follow-up, looking at the whole person, and not relying on a lab number alone are all part of how hyperlysinemia is approached now.